In The Media, USA Today: Mylan CEO: ‘Misconception’ about EpiPen profits
The CEO of the drug maker that sells the EpiPen treatment is expected to defend the company’s controversial price increases when she testifies before Congress on Wednesday amid a firestorm over pharmaceutical profits…
Read more >Crain's Detroit Business: Michigan project to map plan for linking physicians, hospitals, social service organizations
Michigan health officials next year will embark on an ambitious pilot project that they hope will help mend ills the health care system isn’t equipped to fix alone. The goal is to remake the state’s health care system by linking it to social service organizations to more comprehensively coordinate care for patients…
Read more >Crain's Detroit Business, In The Media: Michigan received $709 million from Obamacare to improve health system
Michigan has been one of the nation’s more aggressive states in seeking funds from the Affordable Care Act in the six years since the controversial bill was narrowly approved by Congress in 2010 and signed into law by President Barack Obama…
Read more >In The Media, The Michigan Chronicle: Healthcare disparities in Detroit persist despite progress under Obamacare
With a recent national report indicating profound health disparities between Detroit residents and the rest of the county and state as the backdrop, Detroit’s Wellness Plan Medical Center on Outer Drive has announced an expansion of services. The services will include an onsite Urgent Care Center that accepts all insurances and is now open after hours and weekends at its …
Read more >In The Media, Pittsburgh Post-Gazette: Mylan will offer low-cost generic EpiPen amid outcry
Embattled drugmaker Mylan sought Monday to temper growing outrage over the skyrocketing cost of its lifesaving EpiPen, announcing it would offer a generic version of the auto-injector in the coming weeks that would sell for roughly half the price…
Read more >In The Media, USA Today: Under fire, Mylan to offer EpiPen for 50% less
Drugmaker Mylan said Monday that it will offer a generic version of the life-saving allergy treatment EpiPen for half the list price of the brand-name treatment after it became the center of a national controversy over skyrocketing drug prices…
Read more >In The Media, USA Today: EpiPen maker to offer discounts after price hike firestorm
Drugmaker Mylan (MYL) said Thursday that it would offer discounts on a life-saving allergy shot after generating a firestorm when it implemented sharp price increases for the treatment…
Read more >In The Media, USA Today: Ex-pharma CEO Martin Shkreli defends EpiPen price increase
Pharmaceutical firebrand Martin Shkreli has injected himself into the debate over the skyrocketing price of a life-saving allergy treatment, arguing that the manufacturer of EpiPen doesn’t make much money and instead blaming insurers for not covering the tab…
Read more >Bridge Magazine, In The Media: Amid opioid crisis, few doctors use Michigan’s outdated drug monitoring tool
The case against Dr. Oscar Linares, once the busiest internist in Monroe, Mich., broke five years ago, but paging through the criminal complaint filed against him in 2011 reveals a parade of startling details that time hasn’t softened…
Read more >In The Media, USA Today: Aetna’s exit deals blow to Obamacare, patients
Health insurer Aetna announced late Monday that it is dropping Obamacare insurance in 69% of the counties and 11 of 15 states where it currently offers plans…
Read more >